tazobactam has been researched along with netilmicin in 5 studies
Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (netilmicin) | Trials (netilmicin) | Recent Studies (post-2010) (netilmicin) |
---|---|---|---|---|---|
1,327 | 153 | 694 | 1,108 | 190 | 55 |
Protein | Taxonomy | tazobactam (IC50) | netilmicin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chamard-Neuwirth, C; Cordin, X; Duez, JM; Kazmierczak, A; Pechinot, A; Siebor, E | 1 |
Auvrignon, A; Le Guyader, N; Leverger, G; Portier, E; Tabone, MD; Vu-Thien, H | 1 |
Aksoylar, S; Cetingül, N; Kansoy, S; Kantar, M; Karapinar, D; Kavakli, K | 1 |
2 trial(s) available for tazobactam and netilmicin
Article | Year |
---|---|
Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children.
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Follow-Up Studies; Humans; Infant; Male; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Recurrence; Tazobactam; Treatment Outcome | 2004 |
Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Topics: Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infections; Meropenem; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins | 2004 |
3 other study(ies) available for tazobactam and netilmicin
Article | Year |
---|---|
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
[In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin].
Topics: Amikacin; Amoxicillin; beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Inhibitors; In Vitro Techniques; Netilmicin; Penicillanic Acid; Piperacillin; Tazobactam | 1995 |